High versus Low Blood-Pressure Target in Patients with Septic Shock

Pierre Asfar(Université d'Angers), Ferhat Meziani(Hôpital Civil, Strasbourg), Jean‐François Hamel(Clinical Research Management), Fabien Grelon(Centre Hospitalier du Mans), Bruno Mégarbane(Hôpital Lariboisière), Nadia Anguel(Bicêtre Hospital), Jean‐Paul Mira, Pierre‐François Dequin(Université de Tours), Soizic Gergaud(Intensive Care Society), Nicolas Weiss(Hôpital Européen Georges-Pompidou), François Legay(Centre Hospitalier de Saint-Brieuc), Yves Le Tulzo(Centre Hospitalier Universitaire de Rennes), Marie Conrad(Centre Hospitalier Régional et Universitaire de Nancy), René Robert(Université de Poitiers), Frédéric Gonzalez(Hôpital Avicenne), Christophe Guitton(Nantes Université), Fabienne Tamion(Université de Rouen Normandie), Jean-Marie Tonnelier(Centre Hospitalier Régional Universitaire de Brest), Pierre Guezennec(Centre Hospitalier de Versailles), Thierry Van Der Linden, Antoine Vieillard-Baron(Laboratoire Vision Action Cognition), Éric Mariotte(Saint Louis University Hospital), Gaël Pradel(Laboratoire Informatique d'Avignon), Olivier Lesieur(Centre Hospitalier de La Rochelle), Jean‐Damien Ricard(Université Paris Cité), F. Hervé(Centre Hospitalier de Cornouaille), Damien du Cheyron(Université de Caen Normandie), Claude Guérin(Université d'Angers), Alain Mercat, Jean–Louis Teboul(Bicêtre Hospital), Peter Radermacher(University Hospital Ulm)
New England Journal of Medicine
March 18, 2014
Cited by 1,205Open Access
Full Text

Abstract

BACKGROUND: The Surviving Sepsis Campaign recommends targeting a mean arterial pressure of at least 65 mm Hg during initial resuscitation of patients with septic shock. However, whether this blood-pressure target is more or less effective than a higher target is unknown. METHODS: In a multicenter, open-label trial, we randomly assigned 776 patients with septic shock to undergo resuscitation with a mean arterial pressure target of either 80 to 85 mm Hg (high-target group) or 65 to 70 mm Hg (low-target group). The primary end point was mortality at day 28. RESULTS: At 28 days, there was no significant between-group difference in mortality, with deaths reported in 142 of 388 patients in the high-target group (36.6%) and 132 of 388 patients in the low-target group (34.0%) (hazard ratio in the high-target group, 1.07; 95% confidence interval [CI], 0.84 to 1.38; P=0.57). There was also no significant difference in mortality at 90 days, with 170 deaths (43.8%) and 164 deaths (42.3%), respectively (hazard ratio, 1.04; 95% CI, 0.83 to 1.30; P=0.74). The occurrence of serious adverse events did not differ significantly between the two groups (74 events [19.1%] and 69 events [17.8%], respectively; P=0.64). However, the incidence of newly diagnosed atrial fibrillation was higher in the high-target group than in the low-target group. Among patients with chronic hypertension, those in the high-target group required less renal-replacement therapy than did those in the low-target group, but such therapy was not associated with a difference in mortality. CONCLUSIONS: Targeting a mean arterial pressure of 80 to 85 mm Hg, as compared with 65 to 70 mm Hg, in patients with septic shock undergoing resuscitation did not result in significant differences in mortality at either 28 or 90 days. (Funded by the French Ministry of Health; SEPSISPAM ClinicalTrials.gov number, NCT01149278.).


Related Papers

No related papers found

Powered by citation graph analysis